Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-54387-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2007English

The Influence of Obesity on Results of AT (Doxorubicin Plus Docetaxel) Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients

Polski Przeglad Chirurgiczny
MedicineSurgery
2015English

Epirubicin/Cyclophosphamide Followed by Docetaxel as Primary Systemic Therapy in Breast Cancer

Annals of Cancer Research and Therapy
Cancer ResearchOncologyPharmacology
2014English

Docetaxel, Doxorubicin and Cyclophospharmide as Neoadjuvant Chemotherapy With Primary Prophylactic Stem Cell Growth Factor Support in Locally Advanced Breast Cancer (T3 – T4 , No – 3, Mo)

Research in Oncology
2006English

Prolonged Neoadjuvant Chemotherapy With GM‐CSF in Locally Advanced Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1999English

Survival Benefit of Neoadjuvant Chemotherapy With S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis

Annals of Surgical Oncology
OncologySurgery
2019English

Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer

Genetic Testing and Molecular Biomarkers
MedicineGenetics
2012English

Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer: Neoadjuvant FOLFOXIRI Chemotherapy Followed by Short-Course Radiation and Consolidated XELOX Chemotherapy Prior to Resection

Integrative Clinical Medicine
2019English

Risk Factors Affecting Breast Cancer-Related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy